The research of 3-day Moxifloxacin-based short-term triple thereapies for the eradication of Helicobacter pylori infection

XIAO Qiongyi,ZHU Weimei,LIU Hai,YIN Jing,SHEN Qiu
DOI: https://doi.org/10.3969/j.issn.1673-7210.2009.36.038
2009-01-01
Abstract:Objective:To evaluate the clinical efficacy of Moxifloxacin-based short-term triple thereapies for the eradication of Helicobacter pylori (Hp). Methods:213 cases with Hp infection were randomly divided into 3 groups,A,B,C. 72 cases in A group were treated with Moxifloxacin (0.4 g,qd),Metronidazole (0.4 g,tid),Lansoprazole (30 mg,bid)for 3 days; 73 cases in B group were treated with Moxifloxacin (0.4 g,qd),Metronidazole (0.4 g,tid),Lansoprazole (30 mg,bid) for 7 days; 68 cases in C group were treated with Amoxicillin (1.0 g,bid),Metronidazole (0.4 g,tid),Lansoprazole (30 mg,bid) for 7 days. The end of 4 weeks after stopping treatment with 14C-UBT test whether the eradication of Hp. Results:The eradication rate of Hp in A,B,C group was 72%,93% and 69%. Conclusion:The eradication rate of HP in moxifloxacinbased 3-days is too low,not worth to spread.
What problem does this paper attempt to address?